Comprehensive Overview Of Sickle Cell Disease: Global Impact, Management Strategies, And Future Directions

Main Article Content

Hemraj Singh Rajput
Mamta Kumari
Chitrali Talele
Cyril Sajan
Varunsingh Saggu
Rajesh Hadia

Abstract

In this comprehensive overview of Sickle Cell Disease (SCD), the discussion delves into the intricacies of this genetic disorder, emphasizing the global health implications and the urgent need for effective management strategies. SCD, characterized by abnormal, crescent-shaped red blood cells, manifests in various health problems, including pain crises, anemia, infections, and strokes. The prevalence of SCD globally has witnessed a significant rise, with the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 reporting a 41.4% increase in affected individuals from 2000 to 2021.The discussion further highlights the alarming mortality burden associated with SCD, emphasizing the urgency for comprehensive global strategies to prevent and manage the disease. The molecular basis of SCD, particularly the HbS variant leading to sickle cell anemia (SCA), is explored, with SCA remaining the most prevalent and severe form despite numerous variants. Global distribution of SCD is intricately linked to historical malaria prevalence, with regions like sub-Saharan Africa, the Middle East, and India experiencing higher prevalence. However, disparities in diagnosis and treatment between resource-limited and higher-income countries underscore the need for global recognition and intervention. The multifaceted management of SCD involves early diagnosis, preventive measures, and a multidisciplinary approach to complications. While therapies like hydroxyurea, l-glutamine, and stem cell transplant show promise, ongoing research and global awareness are crucial. Government actions are pivotal in establishing effective public health programs, as illustrated by the varying interventions in India, Italy, and the United States. In conclusion, the discussion outlines the complex landscape of SCD, emphasizing the global impact, the need for ongoing research, and the importance of concerted efforts in disease management and prevention. This comprehensive overview serves as a foundation for informed decision-making and future strategies to address the significant burden of SCD worldwide.

Downloads

Download data is not yet available.

Article Details

How to Cite
Hemraj Singh Rajput, Mamta Kumari, Chitrali Talele, Cyril Sajan, Varunsingh Saggu, & Rajesh Hadia. (2024). Comprehensive Overview Of Sickle Cell Disease: Global Impact, Management Strategies, And Future Directions. Journal of Advanced Zoology, 45(1), 561–566. https://doi.org/10.53555/jaz.v45i1.3390
Section
Articles
Author Biographies

Hemraj Singh Rajput

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

Mamta Kumari

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

Chitrali Talele

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

Cyril Sajan

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

Varunsingh Saggu

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

Rajesh Hadia

Department of Pharmacy, Sumandeep Vidyapeeth deemed to be University, Piparia, Vadodara, Gujarat-391760, India

References

CDC. Articles about Sickle Cell Disease [Internet]. [cited 2022 Jan 6]. Available from: https://www.cdc.gov/ncbddd/sicklecell/articles.html

Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022;15:202.

Global burden of sickle cell disease in 2021 - The Lancet [Internet]. [cited 2022 Jan 6]. Available from: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00446-7/fulltext

Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021.

Sickle cell disease is 11 times more deadly than previously recorded [Internet]. [cited 2022 Jan 6]. Available from: https://www.scidev.net/global/disease/news/sickle-cell-disease-is-11-times-more-deadly-than-previously-recorded/

Brandow AM, Liem RI. Advances in the diagnosis and treatment of sickle cell disease. J Hematol Oncol. 2022;15:201.

Evolutionary history of sickle-cell mutation: implications for global health. Hum Mol Genet. 2021;30(R1):R1192.

Chakravorty S, Williams TN. Sickle cell disease: a neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100:483.

Sickle cell disease: a neglected chronic disease of increasing global health importance [Internet]. [cited 2022 Jan 6]. Available from: https://adc.bmj.com/content/100/5/483

Sickle Cell Anaemia in a Changing World [Internet]. [cited 2022 Jan 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073801/

Advances in the diagnosis and treatment of sickle cell disease [Internet]. [cited 2022 Jan 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268385/

Sickle cell disease treatment and management in India: a systematic review of interventional studies [Internet]. [cited 2022 Jan 6]. Available from: https://pubmed.ncbi.nlm.nih.gov/34716067/

Current challenges in the management of patients with sickle cell disease – A report of the Italian experience [Internet]. [cited 2022 Jan 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6140274/

Specifying sickle cell disease interventions: a study protocol of the National Heart, Lung and Blood Institute [Internet]. [cited 2022 Jan 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598781/

Recent progress in the treatment of sickle cell disease: an up-to-date review [Internet]. [cited 2022 Jan 6]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268621/

World Health Organization. (2021). Global Burden of Diseases, Injuries, and Risk Factors Study (GBD).

Piel FB, et al. Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis. Nature Communications. 2017;8:1467.

Rees DC, et al. Sickle cell disease. The Lancet. 2019;394(10203):176-188.

Kato GJ, et al. Sickle cell disease. Nature Reviews Disease Primers. 2017;3:17010.

Ware RE, de Montalembert M, Tshilolo L. Sickle cell disease. The Lancet. 2019;394(10203):1745-1758.

National Heart, Lung, and Blood Institute. (2021). Evidence-Based Management of Sickle Cell Disease: Expert Panel Report.

Most read articles by the same author(s)